Indegene Ltd. IPO

Indegene is a digital-first life sciences commercialization partner. They focus on biopharma, biotech, and medical device companies, helping them develop, launch, and grow their products throughout the lifecycle. With over 20 years of experience, they combine deep industry knowledge with digital solutions. Their services span marketing, medical affairs, clinical research, and regulatory submissions. Notably, they partner with the top 20 global biopharmaceutical companies.

RHP
View
DRHP
View
Open Date

2024-05-06

Close Date

2024-05-08

Indegene Ltd. IPO Details

Check out the issue details for Indegene Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 452

Price Band

₹ 430 - 452

Issue Size

1841.76 Cr.

Issue Type

Book Built

Open

2024-05-06

Close

2024-05-08

Listingprice

₹ 655

ListingGain

44.91%

Listing Date

2024-05-13

CMP

₹ 640.3

Current Return

41.66%

Indegene Ltd. News

Indegene unveils new center in Hyderabad18 Nov, 2:29PM Indegene - Quaterly Results28 Oct, 7:04PM Indegene - Quaterly Results28 Oct, 7:04PM Indegene informs about press release10 Oct, 12:42PM Indegene informs about Investor Meet16 Sep, 4:20PM Indegene informs about trading window closure 2 Aug, 2:55PM Indegene - Quaterly Results1 Aug, 8:05PM Indegene - Quaterly Results1 Aug, 8:05PM Indegene informs about press release11 Jul, 2:37PM Indegene enters into strategic collaboration with Microsoft11 Jul, 2:24PM Indegene collaborates with Indian Institute of Science, Ignite Life Science Foundation 12 Jun, 2:45PM Indegene informs about outcome of board meeting30 May, 11:47AM Indegene informs about disclosure16 May, 2:50PM Indegene coming with IPO to raise upto Rs 1881 crore3 May, 3:42PM Indegene files Rs 3,200 crore IPO papers with SEBI 16 Dec, 10:04AM

Company Financials

You can get the following financial statements of Indegene Ltd. as of now.

Company Name

Indegene Ltd.

Exchange

NSE: INDGN BSE: 544172

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Indegene Limited IPO is as:

  • The issue size of the IPO is 1841.76 Cr.
  • The price band for Indegene Limited IPO is Rs 430 to Rs 452.
  • The employees of the company will get a discount of Rs 30. 
  • The shares of Indegene Limited IPO will list on 13th May 2024.
  • The latest tentative GMP of Indegene Limited IPO is Rs 260.
  • The shares of Indegene Limited IPO is subscribed 70.30 Times as of 8th May 2024.

 

Indegene Limited IPO Valuation

The approx valuation of Indegene Limited IPO based on its price band and DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 452
Existing Shares (Qty) 22.24 Cr
Fresh Issue 760 Cr
Market Cap 10,812.48 Cr
EPS (FY23) Rs 12.03
PE Ratio 37.57x

 

Indegene Limited IPO Issue Size

Indegene Limited IPO issue size is 1841.76 Cr. 

Issue Amount
Fresh Issue 760 Cr
Offer For Sale 1081.76 Cr

 

Indegene Limited IPO Market Lot

An Individual can apply for a minimum 1 lot of 33 shares and a maximum of 13 lots of 429 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 33 14,916
 Maximum 13 429 1,93,908

 

Indegene Limited IPO share offer

The shares of Indegene Limited IPO is subscribed 70.30 Times as of 8th May 2024. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 192.72 Times
Non-Institutional Minimum 15% 55.91 Times
Retail Individual Minimum 35% 7.86 Times
Employee 2,96,209 Shares 6.62 Times
Total   70.30 Times

Find below the dates for Indegene Limited IPO:

Schedule Date
Basis of Allotment 9 May 2024
Refunds 10 May 2024
Credit to Demat Account 10 May 2024
IPO Listing Date 13 May 2024

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 334.5 511 836.7 1005.7 1045.6
Total Expenditure 248.61 361 668 828.1 877.6
Operating Profit 85.89 150 168.7 177.6 168
Other Income 15.2 24.5 27.8 37.1 50.3
Interest 3.4 3.5 3 6.4 6.6
Depreciation 13.4 17.6 23.6 31.7 31.1
Exceptional Items -43.7 3 0 0 0
Profit Before Tax 40.59 156.4 169.9 176.6 180.6
Provision for Tax 13.8 26.9 37.2 46.4 42.7
Net Profit 31.69 132.4 132.7 130.2 137.9
Adjusted EPS (Rs.) 0.14 0.69 0.53 0.59 0.62

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 0.3 0.3 0.4 44.3 44.4
Total Reserves -3.4 253.6 649.6 751 909.4
Borrowings 315.3 0 0 0 0
Other N/C liabilities 8.1 7.1 48.8 59.4 53.2
Current liabilities 93.8 93.3 140.7 169.4 198.1
Total Liabilities 414.1 354.3 839.5 1024.1 1205.1
Assets
Net Block 9 40.6 72 78.3 56.1
Capital WIP 22.3 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 251.4 83.4 83.4 231.5 385.4
Loans & Advances 12.7 12.3 149.5 11.1 12.5
Other N/C Assets 0.2 0.1 0.1 0.3 0.1
Current Assets 118.5 217.9 534.5 702.9 751
Total Assets 414.1 354.3 839.5 1024.1 1205.1
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2024 Jun 2024 Sep 2024
Other Income 23.1 13.7 22.4
Profit Before Tax 60.4 45.1 61
Tax 11.5 12.5 16.2
Profit After Tax 48.9 32.6 44.8
Adjusted EPS (Rs) 2.2 1.36 1.87

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 40.59 159.9 169.9 176.6 180.6
Adjustment 61.3 11.3 15.5 32.8 2.5
Changes in Assets & Liabilities 2.7 -92.3 -111.3 -85.7 42.4
Tax Paid -15 -25.6 -35.9 -41.8 -49.3
Operating Cash Flow 89.5 53.3 38.2 81.9 176.2
Investing Cash Flow -51 -34.1 -266.9 -51 -189
Financing Cash Flow -18.5 -37.1 244.9 -16.9 -15.8
Net Cash Flow 20 -17.9 16.2 14 -28.6
X